The commercial success of second-generation radiopharmaceuticals in oncology has re-ignited interest in this modality, resulting in a surge of dealmaking and increased venture financing for companies in the field.
Read MoreWhile psychedelic drugs have been historically stigmatized due to their use as recreational drugs, the commercialization of psychedelics and psychedelic-derived compounds for the treatment of psychiatric and neurological disorders has gained significant momentum over the last 5 years. Two events are seen as watershed moments for the surge of interest in psychedelics.
Read MoreRobotic surgery is primed for an acceleration in activity – both in its clinical utilization as well as its strategic importance to the venture community and consolidators alike.
Given the significant opportunity to grow the overall market, the next wave of exciting robotic surgery innovations has caught the eye of medtech investors.
Read More